Time‐dependent benefits of pre‐treatment with new oral P2Y 12 ‐inhibitors in patients addressed to primary PCI for acute ST‐elevation myocardial infarction-Reference-Cited by-同舟云学术

Time‐dependent benefits of pre‐treatment with new oral P2Y 12 ‐inhibitors in patients addressed to primary PCI for acute ST‐elevation myocardial infarction

Published:2018-09-30 Issue:4 Volume:93 Page:592-601
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Catheter Cardiovasc Interv

Author:

Pepe Martino¹^ORCID,Cafaro Alessandro²,Paradies Valeria³^ORCID,Signore Nicola⁴,Addabbo Francesco⁵,Bortone Alessandro Santo⁶,Navarese Eliano Pio⁷⁸,Contegiacomo Gaetano⁹,Forleo Cinzia¹,Bartolomucci Francesco¹⁰,Di Cillo Ottavio¹¹,Bianchi Francesco Paolo¹²,Zanna Domenico¹,Favale Stefano¹

Affiliation:

1. Division of Cardiology, Department of Emergency and Organ TransplantationUniversity of Bari Bari Italy

2. Cardiovascular DepartmentF. Miulli Hospital Acquaviva delle Fonti Italy

3. Department of CardiologyMaasstad Ziekenhuis Hospital Rotterdam Netherlands

4. Division of CardiologyAzienda Ospedaliero Universitaria Consorziale Policlinico di Bari Bari Italy

5. Department of Biomedical Sciences & Human OncologyUniversity of Bari Medical School Bari Italy

6. Division of Heart Surgery, Department of Emergency and Organ TransplantationUniversity of Bari Bari Italy

7. Inova Heart and Vascular Institute Falls Church Virginia

8. Interventional Cardiology and Cardiovascular Research, Mater Dei Hospital Bari Italy

9. Interventional Cardiology and Cardiovascular ResearchMater Dei Hospital Bari Italy

10. Division of CardiologyBonomo Hospital Andria Italy

11. Chest Pain Unit, Cardiology EmergencyUniversity of Bari Bari Italy

12. Department of Biomedical Science and Human OncologyUniversity of Bari Bari Italy

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccd.27863

Reference32 articles.

1. Effect of Clopidogrel Pretreatment on Angiographic and Clinical Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Acute Myocardial Infarction

2. Clopidogrel pre-treatment is associated with reduced in-hospital mortality in primary percutaneous coronary intervention for acute ST-elevation myocardial infarction

3. Impact of Pretreatment With Clopidogrel on Initial Patency and Outcome in Patients Treated With Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

4. Prehospital clopidogrel administration in patients with ST‐segment elevation myocardial infarction treated with primary PCI: Real‐life experience from the multicentre NRDES registry;Rakowski T;J Invas Cardiol,2016

5. Outcome Comparison of 600- and 300-mg Loading Doses of Clopidogrel in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Timing of P2Y12 Inhibitor Administration in Patients With STEMI Undergoing Primary PCI;Journal of the American College of Cardiology;2024-06

2. Effectiveness and Safety of P2Y12 Inhibitor Pretreatment for Primary PCI in STEMI: Systematic Review and Meta-analysis;Journal of Cardiovascular Pharmacology;2023-10

3. Comparative effectiveness of Cangrelor in patients with acute coronary syndrome undergoing percutaneous coronary intervention: an observational investigation from the M.O.Ca. registry;Scientific Reports;2023-07-01

4. Effectiveness and safety of P2Y12 inhibitor pretreatment for primary PCI in STEMI: Systematic review and meta-analysis;2023-01-16

5. Comparative effectiveness of Cangrelor in patients with acute coronary syndrome undergoing percutaneous coronary intervention: Insights from the multicenter M.O.Ca. registry;2023-01-04